Match Document Document Title
6194440 Small molecule carbamate or urea hair growth compositions and uses  
This invention relates to pharmaceutical compositions and methods for treating alopecia and promoting hair growth using small molecule carbamates and ureas.
6194450 Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof  
Novel pharmaceutically/cosmetically-active polyaromatic heterocyclic compounds have the structural formula (I): ##STR1## in which Z is a divalent radical selected from among --O--, --S-- or --Nr'--...
6187752 Method for treating schizophrenia employing an ace inhibitor  
A method is provided for treating schizophrenia in a mammalian species by administering an ACE inhibitor, such as captopril, alone or with a neuroleptic such as cholecystokinin, fluphenazine or...
6180626 Vascular-permeability suppressants  
A vascular permeability suppressant includes an oxaspirooctane derivative of the general formula (I): ##STR1## [wherein, R 1 represents, for example, lower alkylcarbamoyl group or protected...
RE37035 Phenylacetic acid benzylamides  
Phenylacetic acid benzylamides having the following general structure ##STR1## wherein the substituents are defined herein, are disclosed, which compounds are hypoglcemic agents.
6177408 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents  
A compound which is a distamycin derivative of formula (I), wherein n is 2, 3 or 4; R 0 is C 1 -C 4 alkyl or C 1 -C 3 haloalkyl; R 1 and R 2 , which may be the same or different, are each...
6174898 Method of treating filariae  
The present invention relates to a novel method for treating a mammal suffering from filariae.
6174879 Aminocyclohexylesters and uses thereof  
Aminocyclohexylester compounds, including thioesters, are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a...
6172102 Pyrrole derivatives and medicinal composition  
The invention relates to a pharmaceutical composition comprising a pyrrole derivative of the following formula [1] or a pharmaceutically acceptable salt thereof, or a solvate of either of them, as...
6166015 Pyrrolidine derivatives-CCR-3 receptor antagonists  
This invention relates to certain 3-aminomethylpyrrolidine derivatives of Formula (I): ##STR1## that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their...
6166082 Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors  
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have...
6166068 Immunomodulator, cell adhesion inhibitor, and agent for treating, and preventing autoimmune diseases  
Autoimmune diseases, cell adhesion inhibition and immunomodulation are treated or effected by a method, comprising, treating a patient with a therapeutically effective amount of a...
6160004 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities  
The present invention provides a two-step procedure for the replacement of the pyranose anomeric 10-OH group in dihydroartemisinin by a variety of carbon nucleophiles, resulting in the novel C-10...
6156787 Substituted thienlycyclohexanone derivatives for enhancing cognition  
The present invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof: ##STR1## where A is C 1 -6 alkyl, C 2 -6 alkenyl, C 2 -6 alkynyl, C 3 -6 cycloalkyl, arylC 1 -6...
6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders  
The present invention relates to the use of pyrrolidine and piperidine derivatives of the general formula ##STR1## wherein R 1 and R 2 are, independently from each other, hydrogen, lower alkoxy,...
6147092 Lipophilic benzothiophenes  
The invention provides novel benzothiophenes of the formula (I): ##STR1## wherein R 1 is N-pyrrolidinyl or N-piperidinyl; R 2 and R 3 are independently hydrogen,--CO--(C 10 -C 22 alkyl),...
6140338 Chemokine receptor antagonists  
The present invention relates to a compound of the general formula: ##STR1## wherein each of R 1 and R 2 which may be the same or different, is e.g. a hydrogen atom, a halogen atom or a lower...
6140321 Polymorphs of donepezil hydrochloride and process for production  
Donepezil hydrochloride, 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride, is provided here in the form of four polymorphs which are stable against heat and humidity in the...
6136844 5-aroylpyrrol-2-ylmethylarene derivatives  
Compounds selected from the group of compounds represented by formula I: ##STR1## where: R 10 is represented by the formula (A), (B), or (C): ##STR2## R 20 is represented by the formula (U), (V),...
6136847 Water-soluble trioxanes as potent and safe antimalarial agents  
Biologically-active, water soluble, 3-substituted trioxanes of the formula ##STR1## wherein R represents a COOH-- substituted aryl group, a substituted or unsubstituted heteroaryl group or an alkyl...
6133288 Pentacyclic compounds, intermediates, processes, compositions, and methods  
The present invention provides compounds of formula I and II: ##STR1## wherein X is --O--, --S--, or --NR 5 --; Y is --O--, --S--, --CH 2 --, --CH 2 CH 2 --, --CHCH--, or --NR 5 --; B...
6133307 Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists  
The novel compounds of formula (I) of the instant invention are selective kappa opioid agonists useful in the treatment of arthritis, hypertension, pain, inflammation, migraine, inflammatory...
6133279 Therapeutic agents for renal diseases and organ preservatives  
Herein disclosed are therapeutic agents for renal diseases and organ preservatives containing a compound represented by the general formula (1): ##STR1## wherein X represents an oxygen atom or a...
6124341 Endothelin antagonists  
A compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of...
6124319 3,3-disubstituted piperidines as modulators of chemokine receptor activity  
The present invention is directed to 3,3-disubstituted piperidines of the formula I: ##STR1## (wherein X, Y, Z, Ar, R, m and n are defined herein) which are useful as modulators of chemokine...
6124277 Antithrombotic agents  
This invention relates to peptide derivatives, pharmaceutical formulations containing those compound and methods of their use as thrombin inhibitors.
6124311 Methods for treating resistant tumors  
The present invention provides methods for reversing multidrug resistance in a resistant neoplasm by treating a mammal in need of said treatment with a substituted indole, benzofuran,...
6121309 Fused-ring carboxylic acid derivatives  
The present invention provides a medicament exhibiting excellent retinoic acid receptor agonism. A Carboxylic acid derivative having a fused ring which is represented by the following formula or a...
6121293 Benzothiophene compounds, compositions, and methods  
The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions...
6121310 Aflatoxin contamination inhibitor and aflatoxin contamination-inhibiting method  
An aflatoxin contamination inhibitor, which contains an actibiotic Blasticidin A of the following chemical formula (1) or its salt, ##STR1## and at least one selected from a solid carrier, a liquid...
6110947 Pyrrolidinyl hydroxamic acid compounds and their production process  
A compound of the formula: ##STR1## and it pharmaceutically acceptable salt, wherein A is hydrogen, hydroxy or OY, where Y is a hydroxy protecting group; Ar is phenyl optionally substituted with...
6107311 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents  
A compound having the structure: ##STR1## wherein (a) n is from 1 to about 3; (b) X is selected from the group consisting of O, S, SO, or SO 2 ; (c) Y is independently hydrogen or straight,...
6106864 Pharmaceutical formulations containing darifenacin  
There is provided a pharmaceutical dosage form adapted for administration to the gastrointestinal tract of a patient, comprising darifenacin, or a pharmaceutically acceptable salt thereof, and a...
6103713 Therapeutic treatment for autoimmune diseases  
Methods for inhibiting activation and/or proliferation of T cells and B cells and for treating autoimmune diseases and/or disease manifestations are disclosed, particularly using the isozyme...
6103757 Methods for treating arrhythmia using acetate buffer solutions of amiodarone  
Disclosed herein are methods for treating human patients suffering from arrhythmia comprising administration to the human a solutions containing a 3-diethylaminoethoxybenzoyl-benzofuran in acetate...
6096764 Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration  
A method of inhibiting detrimental side-effects of GnRH or GnRH agonist administration in a mammal which comprises the administration to a mannal in need thereof of an effective amount of a...
6096766 3-benzylaminopiperidines as tachykinin receptor antagonists  
6075023 Method for combatting fish mycoses and one-celled ectoparasites  
6071947 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation  
The present invention relates to substituted (1H-indol-2-yl)-5[(2H-pyrrol-2-ylidene) methyl]-1H-pyrrole compounds and their use as immunomodulating agents, to the preparation of the compounds and...
6066662 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents  
The invention provides hydroxylamine derivatives of formula (I) wherein A, R 1 , R 2 and R 3 have the significance given in the description, which are matrix metalloproteinase inhibitors and...
6066652 Method for treating diseases of the inner ear using adamantane derivatives  
6060488 Benzothiophenes for treating estrogen deficiency  
This invention is related to novel benzothiophene compounds of formula I: ##STR1## where R, R 1 , R 2 , X and m are as defined in the specification, which are useful for the inhibition of the...
6057341 Bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics  
6057357 Peripherally selective kappa opioid agonists  
The compounds of the instant invention as those of Formula I ##STR1## or a pharmaceutically acceptable salt thereof are peripherally selective kappa opioid agonists that are useful in treating...
6057342 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof  
The present application describes amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt forms thereof,...
6051593 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors  
The present invention relates to novel 3-(cycloalkanoheteroarylidenyl)-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which are expected to modulate the activity...
6043269 cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes  
The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel...
6040317 Sulfonamide fibrinogen receptor antagonists  
A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases...
6037340 Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds  
Methods for preparing thiophene and pyrrole-based heterocyclic compounds are disclosed. Also disclosed are libraries of thiophene and pyrrole-based heterocyclic compounds, methods for preparing the...
RE36617 (Substituted aralkyl) heterocyclic compounds  
A (substituted-aralkyl)heterocyclic compound of the formula I ##STR1## wherein R 1 is an azido, carbamoyl, cyano, formyl, hydroxy or nitro radical, a 1-6C 1-hydroxyalkyl, alkoxy, alkylcarbamoyl,...